Environmental, Social and Governance (ESG) Report

ClinPlus continuously strengthens its management system, drives development through innovation, and actively advances ESG practices. As always, we listen to the needs of all our stakeholders, respond to their concerns, and strive to create lasting enterprise value while delivering greater positive impact for society and the environment.
ClinPlus


ClinPlus (Shanghai) Pharmaceutical Technology Development Co., Ltd. (301257.SZ), founded in 2013, is a big-data-driven clinical research service provider committed to undertaking clinical research projects for innovative new drugs with high clinical value, helping sponsors efficiently and rapidly advance the implementation and execution of clinical trials, and empowering new drug R&D.
The Company specializes in providing outsourced clinical research and development services to domestic and international pharmaceutical companies, medical device companies, and certain health-related products. Drawing on its long-accumulated clinical trial project execution experience, the Company offers customers a full suite of services — including preparatory planning, site initiation, on-site execution, and end-to-end project management. Through professional project management capabilities, the Company improves trial execution efficiency, effectively controls trial costs, and enhances execution quality. As a result, it maintains stable cooperative relationships and strong client stickiness with its customers, effectively empowering them throughout the clinical development process.

Practicing Green Sustainability


Formally joined the Science Based Targets initiative (SBTi) in 2025

Rated B on the CDP Climate Change Questionnaire

Promoting green office practices, digital carbon reduction, and low-carbon commuting

Practicing Social Responsibility


208

Educational-outreach videos

648

Educational-outreach articles published in total.

Established the trial participant service brand "Ruizhi Home" to raise public awareness of clinical trial-related knowledge and health management concepts.

933

Donated books to Yixilaimuqi Township Primary School No. 1 in Wensu County, Xinjiang, establishing the school's first "Aiding Xinjiang Library".

Over 60,000

Thank-you letters received, covering multiple stakeholders including Sponsors, Trial Participants, Investigators, and Research Institutions.

Empowering Employee Development


24,000+

Internal training videos on our learning platform

113+

Hours of training per employee on average

279

Hours of training for new hires

60+

Professional training sessions hosted for clinical trial institutions

25,000+

Participants reached through external training programs

Lean Execution Empowering Clinical Trials


330+

SOP documents in our quality management system

490,000+

Cumulative trial participant visits, helping participants — especially those with rare diseases — access the world's most advanced treatments and therapies

0 Major Findings

As of the end of 2025, ClinPlus has cumulatively passed 329 NMPA inspections, 15 FDA inspections, and 5 EMA inspections, all with no major findings

Source: ClinPlus 2025 Annual Environmental, Social and Governance (ESG) Report

Quality Forges Core Competitiveness.
Innovation Illuminates a Sustainable Future.

Award certificate Award certificate Award certificate
ClinPlus 2025 ESG Report
ClinPlus 2025 Annual

Environmental Social and Governance (ESG) Report

ClinPlus 2024 ESG Report
ClinPlus 2024 Annual

Environmental Social and Governance (ESG) Report